Gene · 11009
IL24: interleukin 24
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. IL24: interleukin 24. Genes, record 11009. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/11009
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q13007 | Interleukin-24 | 206 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents68
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 12473363 B2 | 2025-11-18 | 920 | Q13007 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4724 | Q13007 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 7016 | Q13007 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 6726 | Q13007 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 6726 | Q13007 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 7016 | Q13007 | Espacenet |
| KR 1020250017231 A | 2025-02-04 | 4724 | Q13007 | Espacenet |
| JP 2025502229 A | 2025-01-24 | 920 | Q13007 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 7016 | Q13007 | Espacenet |
| WO 2024249507 A1 | 2024-12-05 | 98 | Q13007 | Espacenet |
1 to 10 of 68
See all 68 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,348
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IL24 papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 48 | 2025 |
| P30CA016059 | Massey Cancer Center - Cancer Center Support Grant | 16 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| U54MD012392 | RCMI Center for Health Disparities Research | 6 | 2025 |
| P01CA097132 | Sphingolipids in Cancer Biology and Therapy | 5 | 2025 |
| P30AR075043 | University of Michigan Skin Biology and Diseases Resource-based Center | 5 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 5 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 5 | 2025 |
| R01CA259599 | Interplay between tumor and microenvironment in bone metastasis | 4 | 2025 |
| ZIAAI001065 | India International Center for Excellence in Research | 4 | 2025 |
1 to 10 of 1,348Source NIH's project files
See all 1,348 nih grantsPapers2,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PRELP-associated transcriptomic remodeling links alternative splicing and immune checkpoint blockade outcome in melanoma. | Front Immunol | 2026 | 42813001 | PubTator, text mining | PubMed |
| Interleukin-24 Induces Inflammatory Chemokine and Cytokine Responses in Fibroblast-Enriched Synovial Cells from Patients with Knee Osteoarthritis. | Biomedicines | 2026 | 42792825 | PubTator, text mining | PubMed |
| BRD4 contributes to the cytokine-induced acquisition of an IL-13RA2-positive inflammatory fibroblast phenotype. | J Crohns Colitis | 2026 | 42635600 | PubTator, text mining | PubMed |
| Potent Inhibition of Dengue Virus Infection by Synthetic Compound TXD-174 Through Specific Targeting of IL-24. | J Med Virol | 2026 | 42557990 | PubTator, text mining | PubMed |
| Plasma IL-24 is associated with time to first fall in Parkinson's disease. | J Neuroimmunol | 2026 | 42543049 | PubTator, text mining | PubMed |
| Target pathway validation for Compound Kushen Injection active against cancer cells. | Phytomedicine | 2026 | 42492264 | PubTator, text mining | PubMed |
| Causal Insights Into Crohn's Disease: The Role of Oxidative Stress and Genetic Variants. | J Cell Mol Med | 2026 | 42458727 | PubTator, text mining | PubMed |
| Exploring the mechanism of interleukin-24 in regulating eosinophil differentiation in chronic obstructive pulmonary disease. | Respir Res | 2026 | 42458434 | PubTator, text mining | PubMed |
| Integrated Genomic, Transcriptomic, and Circulating Biomarkers Predict Benefit to Immune Checkpoint Inhibitor Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer. | MedComm (2020) | 2026 | 42415854 | PubTator, text mining | PubMed |
| Microwave treatment of human papillomavirus-positive in vitro grown epithelial tissues results in a rapid stress-related transcriptional response and induction of innate immunity. | Int J Hyperthermia | 2026 | 42381515 | PubTator, text mining | PubMed |
1 to 10 of 2,968
See all 2,968 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/11009
GET https://conductscience.org/api/genes/v1/11009/patents?page=2